| 👁 Image | |
| Clinical data | |
|---|---|
| Other names | RU41656; 6-Methyl-8-[(methylthio)methyl]-9-oxaergoline |
| Drug class | Dopamine D2 receptor agonist |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H20N2OS |
| Molar mass | 288.41 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Voxergolide (INN; developmental code name RU-41656), also known as 6-methyl-8-[(methylthio)methyl]-9-oxaergoline, is a dopamine receptor agonist of the 9-oxaergoline family described as an anti-anoxic and anti-ischemic agent which was never marketed.[1][2][3] It acts specifically as a dopamine D2 receptor agonist.[4][3]
See also
[edit]- Substituted 9-oxaergoline
- RU-29717 (N-propyl-9-oxaergoline)
- 6-Ethyl-9-oxaergoline (EOE)
- Naxagolide
References
[edit]- ^ Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. William Andrew Publishing. 2013. p. 3460. ISBN 978-0-8155-1856-3. Retrieved 23 February 2025.
- ^ Negwer M (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akad.-Verlag. p. 1179. ISBN 978-3-05-500156-7. Retrieved 23 February 2025.
- ^ a b Patat A, Klein MJ, Surjus A, Hucher M, Granier J (1991). "RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers". European Journal of Clinical Pharmacology. 41 (3): 225–231. doi:10.1007/BF00315434. PMID 1684155.
- ^ Willig F, Van de Velde D, Laurent J, M'Harzi M, Delacour J (1992). "The Roman strains of rats as a psychogenetic tool for pharmacological investigation of working memory: example with RU 41656". Psychopharmacology. 107 (2–3): 415–424. doi:10.1007/BF02245169. PMID 1352059.
Hidden categories: